Skip to main content

Peer Review reports

From: Protocol of the EFFORT study: a prospective study of FOLFIRI plus aflibercept as second-line treatment after progression on FOLFOXIRI plus bevacizumab or during maintenance treatment in patients with unresectable/metastatic colorectal cancer

Original Submission
21 Jul 2020 Submitted Original manuscript
22 Sep 2020 Author responded Author comments - Hironaga Satake
21 Aug 2020 Reviewed Reviewer Report
24 Aug 2020 Reviewed Reviewer Report
Resubmission - Version 2
22 Sep 2020 Submitted Manuscript version 2
21 Oct 2020 Author responded Author comments - Hironaga Satake
Resubmission - Version 3
21 Oct 2020 Submitted Manuscript version 3
Publishing
26 Oct 2020 Editorially accepted
17 Nov 2020 Article published 10.1186/s12885-020-07576-9

You can find further information about peer review here.

Back to article page
\